Key regions: Germany, Europe, South Korea, France, China
The Skin Treatment (Pharmacies) market in G7 countries is experiencing steady growth due to increasing customer preferences for skincare products, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Customers in G7 countries are increasingly prioritizing skincare and are willing to invest in high-quality skin treatment products. There is a growing awareness of the importance of maintaining healthy skin, which has led to a surge in demand for skincare products in pharmacies. Customers prefer products that are dermatologically tested, free from harmful chemicals, and offer visible results. Additionally, there is a rising demand for natural and organic skincare products, as customers become more conscious of the ingredients used in their skincare routine.
Trends in the market: One of the key trends in the Skin Treatment (Pharmacies) market in G7 countries is the growing popularity of anti-aging products. As the population ages, there is a higher demand for skincare products that target signs of aging, such as wrinkles and fine lines. This trend is driving the development of innovative anti-aging formulas and technologies in the market. Another trend in the market is the increasing demand for personalized skincare solutions. Customers are looking for products that cater to their specific skin concerns and needs. This has led to the rise of customized skincare solutions, where customers can have their skin analyzed and receive personalized recommendations for products that address their individual concerns.
Local special circumstances: Each G7 country has its own unique set of local special circumstances that influence the Skin Treatment (Pharmacies) market. For example, in the United States, there is a strong emphasis on natural and organic skincare products, driven by a growing consumer preference for clean beauty. In Japan, there is a focus on advanced skincare technologies and innovative ingredients. In Germany, there is a high demand for dermatologist-recommended products, as customers value the expertise and trust associated with medical professionals.
Underlying macroeconomic factors: The Skin Treatment (Pharmacies) market in G7 countries is also influenced by underlying macroeconomic factors. Factors such as disposable income, employment rates, and consumer confidence play a significant role in driving market growth. As the economy improves and consumer purchasing power increases, customers are more willing to invest in skincare products. Additionally, the growing middle-class population in some G7 countries has contributed to the expansion of the market, as more individuals have the financial means to afford skincare products. In conclusion, the Skin Treatment (Pharmacies) market in G7 countries is experiencing growth due to customer preferences for skincare products, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for high-quality skincare products, including anti-aging solutions and personalized skincare, is driving market growth. Each G7 country has its own unique set of local special circumstances that influence the market, and underlying macroeconomic factors such as disposable income and consumer confidence also play a significant role.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
